A woman gets her temperature taken before receiving free food during the coronavirus disease (COVID-19) outbreak in Bangkok, Thailand on Apr 27, 2020. (Photo by=Reuters/Athit Perawongmetha) |
[아시아뉴스통신=레악카나 기자] Thai researchers plan to begin human trials of a potential vaccine for the new coronavirus in November and are preparing 10,000 doses, a senior official said on Sunday (Jul 12), aiming for a vaccine that could be ready for use by late next year. Following favourable results in trials on primates, the next step is to manufacture doses for human trials, said Kiat Ruxrungtham, director of Bangkok's Chulalongkorn University vaccine development program.
Thailand's first facility should complete production in October and send the products to a second facility, which should finish by November, he said. Originally the earliest target was September, but Kiat said not enough vaccines can be ready by then.
The trials will not accept volunteers "until we receive approval from the Thai Food and Drug Administration and an ethics committee”, Kiat said.Thai company BioNet-Asia is preparing its facilities for large-scale manufacturing if the trials prove successful, he said. “If everything goes according to plan, the vaccine will be ready for Thailand in the third or fourth quarter next year,” Kiat said. There are no approved vaccines for the virus that causes COVID-19, but 19 candidates are being trailed in humans globally. China is leading the race, with an experimental vaccine by Sinovac Biotech.